.png){kind=small}
Glucagon Market Overview
The global glucagon market is witnessing steady growth due to increasing prevalence of diabetes and hypoglycemia, coupled with rising awareness of emergency treatments. Glucagon, a critical hormone used to raise blood glucose levels, is primarily prescribed for severe hypoglycemic episodes, especially in individuals with diabetes who rely on insulin therapy. With diabetes affecting millions worldwide, demand for glucagon products continues to rise, creating opportunities for pharmaceutical companies and healthcare providers.
Market Drivers
Several factors are driving the growth of the glucagon market:
Rising Diabetes Prevalence: The number of people diagnosed with diabetes is growing globally, particularly in North America, Europe, and Asia-Pacific. This increases the need for emergency treatments, including glucagon.
Innovations in Delivery Systems: Traditional glucagon administration involves injection, which can be challenging in emergencies. Newer delivery systems, such as nasal glucagon and auto-injectors, simplify usage and improve patient compliance, driving market adoption.
